Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Vascular Diseases

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Vascular Diseases in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gebhard, C1
Breitenstein, A1
Akhmedov, A1
Gebhard, CE1
Camici, GG1
Lüscher, TF1
Tanner, FC1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Vascular Diseases

ArticleYear
Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4.
    European heart journal, 2010, Volume: 31, Issue:14

    Topics: Amphetamines; Aorta; Blood Coagulation; Blotting, Western; Cells, Cultured; Down-Regulation; Endothe

2010